Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-17

Clinical Trial Update: Adjunctive Clindamycin for Cellulitis: C4C Trial. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating adjunctive clindamycin for cellulitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clindamycin

Snippet

Sponsor: University Hospitals Bristol and Weston NHS Foundation Trust | Conditions: Cellulitis | Phase 4 | Status: COMPLETED